These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 37914418)

  • 1. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
    Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy.
    González-Torralba F; Baloira A; Abad A; Fuster A; García-Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1005-1015. PubMed ID: 35547784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical problems with aerosol therapy in COPD.
    Rau JL
    Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
    Brand P; Hederer B; Austen G; Dewberry H; Meyer T
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow Structure and Particle Deposition Analyses for Optimization of a Pressurized Metered Dose Inhaler (pMDI) in a Model of Tracheobronchial Airway.
    Ahookhosh K; Saidi M; Mohammadpourfard M; Aminfar H; Hamishehkar H; Farnoud A; Schmid O
    Eur J Pharm Sci; 2021 Sep; 164():105911. PubMed ID: 34129919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler.
    Sorino C; Negri S; Spanevello A; Visca D; Scichilone N
    Eur J Intern Med; 2020 May; 75():15-18. PubMed ID: 32113944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
    Takaku Y; Kurashima K; Ohta C; Ishiguro T; Kagiyama N; Yanagisawa T; Takayanagi N
    Respir Med; 2017 Feb; 123():110-115. PubMed ID: 28137486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosol Plumes of Inhalers Used in COPD.
    Wachtel H; Emerson-Stadler R; Langguth P; Hohlfeld JM; Ohar J
    Pulm Ther; 2024 Mar; 10(1):109-122. PubMed ID: 38194194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of inhaler devices in pediatric asthma.
    De Benedictis FM; Selvaggio D
    Paediatr Drugs; 2003; 5(9):629-38. PubMed ID: 12956619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key issues in inhalation therapy in children.
    Brand PL
    Curr Med Res Opin; 2005; 21 Suppl 4():S27-32. PubMed ID: 16138942
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Davis MD; Saunders JL; Ringer C; Engberg R; Zhao Y; DiBlasi RM; Rubin BK
    J Breath Res; 2023 Apr; 17(3):. PubMed ID: 36996807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDI.
    Balamurugan S; Apte K; Singh BP; Deb AK; Deshmukh C; Modi K; Godse A; Dhar R; Lahiri KR; Singh V; Pandya H; Rajan S; Vaidya A; Gaur V; Gogtay J
    Respir Med; 2020 Jan; 161():105707. PubMed ID: 32056719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus.
    García-Río F; Soler-Cataluña JJ; Alcazar B; Viejo JL; Miravitlles M
    COPD; 2017 Dec; 14(6):573-580. PubMed ID: 28891722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhalation therapy with Respimat soft inhaler in patients with COPD and asthma].
    Voshaar T; Hausen T; Kardos P; Köhler D; Schultze-Werninghaus G; Schürmann W; Vogelmeier C
    Pneumologie; 2005 Jan; 59(1):25-32. PubMed ID: 15685486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration Technique and Acceptance of Inhaler Devices in Patients With Asthma or COPD.
    Sadowski CA; Cor K; Cave A; Banh HL
    Ann Pharmacother; 2015 Jun; 49(6):639-48. PubMed ID: 25814632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.